Skip to main content


  • AddRemove
  • Build a Report 
Media Coverage

23andme relaunches its expanded DNA spit tests after FDA-mandated pause

22 October 2015
USA Today
Litigation & Dispute Resolution partner Mark Mansour (Washington DC) is quoted in this article discussing biotech companies dealing with FDA inquiries.

The Build a Report feature requires the use of cookies to function properly.  Cookies are small text files that are placed on your computer by websites that you visit. They are widely used in order to make websites work, or work more efficiently.  If you do not accept cookies, this function will not work.  For more information please see our Privacy Policy

You have no pages selected. Please select pages to email then resubmit.